The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality

Toshiaki Hitomi, Toshiyuki Habu, Hatasu Kobayashi, Hiroko Okuda, Kouji H. Harada, Kenji Osafune, Daisuke Taura, Masakatsu Sone, Isao Asaka, Tomonaga Ameku, Akira Watanabe, Tomoko Kasahara, Tomomi Sudo, Fumihiko Shiota, Hirokuni Hashikata, Yasushi Takagi, Daisuke Morito, Susumu Miyamoto, Kazuwa Nakao, Akio Koizumi

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)


Moyamoya disease (MMD) is a cerebrovascular disease characterized by occlusive lesions in the Circle of Willis. The RNF213 R4810K polymorphism increases susceptibility to MMD. In the present study, we characterized phenotypes caused by overexpression of RNF213 wild type and R4810K variant in the cell cycle to investigate the mechanism of proliferation inhibition. Overexpression of RNF213 R4810K in HeLa cells inhibited cell proliferation and extended the time of mitosis 4-fold. Ablation of spindle checkpoint by depletion of mitotic arrest deficiency 2 (MAD2) did not shorten the time of mitosis. Mitotic morphology in HeLa cells revealed that MAD2 colocalized with RNF213 R4810K. Immunoprecipitation revealed an RNF213/MAD2 complex: R4810K formed a complex with MAD2 more readily than RNF213 wild-type. Desynchronized localization of MAD2 was observed more frequently during mitosis in fibroblasts from patients (n= 3, 61.0. ±. 8.2%) compared with wild-type subjects (n= 6, 13.1. ±. 7.7%; p<. 0.01). Aneuploidy was observed more frequently in fibroblasts (p<. 0.01) and induced pluripotent stem cells (iPSCs) (p<. 0.03) from patients than from wild-type subjects. Vascular endothelial cells differentiated from iPSCs (iPSECs) of patients and an unaffected carrier had a longer time from prometaphase to metaphase than those from controls (p<. 0.05). iPSECs from the patients and unaffected carrier had significantly increased mitotic failure rates compared with controls (p<. 0.05). Thus, RNF213 R4810K induced mitotic abnormalities and increased risk of genomic instability.

Original languageEnglish
Pages (from-to)419-426
Number of pages8
JournalBiochemical and biophysical research communications
Issue number4
Publication statusPublished - 2013 Oct 4
Externally publishedYes


  • Genomic instability
  • IPS cells
  • MAD2
  • Mitotic phase
  • Moyamoya disease
  • Rs112735431

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality'. Together they form a unique fingerprint.

Cite this